JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
OrthoPediatrics
KIDS
$593M
| $1.5M | ﹤0.01% |
33,953
+9,164
| +37% | +$349K |
2017 Q4
5 quarters
|
|
3377
Neuronetics
STIM
$168M
| $1.5M | ﹤0.01% |
98,471
+51,143
| +108% | +$846K |
2018 Q3
2 quarters
|
|
3378
Markel Group
MKL
$21.5B
| $1.5M | ﹤0.01% |
1,501
-4,772
| -76% | -$4.85M |
2013 Q2
23 quarters
|
|
3379
PUT
TG Therapeutics
TGTX
$7.99B
| $1.49M | ﹤0.01% |
+185,700
| New | +$1M |
2019 Q1
0 quarters
|
|
3380
CapForce IBD 50 ETF
FFTY
$76.7M
| $1.49M | ﹤0.01% |
44,505
+44,170
| +13,185% | +$1.39M |
2017 Q4
5 quarters
|
|
3381
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.64B
| $1.49M | ﹤0.01% |
21,958
+3,000
| +16% | +$195K |
2017 Q3
6 quarters
|
|
|
AQUA
3382
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.49M | ﹤0.01% |
118,150
-49,841
| -30% | -$593K |
2017 Q4
5 quarters
|
|
3383
Sierra Bancorp
BSRR
$512M
| $1.49M | ﹤0.01% |
61,087
+2,991
| +5% | +$77.6K |
2013 Q2
23 quarters
|
|
3384
Frontdoor
FTDR
$5.43B
| $1.49M | ﹤0.01% |
43,142
-4,854
| -10% | -$148K |
2018 Q4
1 quarter
|
|
|
AVDR
3385
DELISTED
Avedro, Inc Common Stock
AVDR
| $1.49M | ﹤0.01% |
+121,014
| New | +$1.51M |
2019 Q1
0 quarters
|
|
|
PENG
3386
Penguin Solutions Inc
PENG
$3.29B
| $1.48M | ﹤0.01% |
154,614
+145,004
| +1,509% | +$1.88M |
2017 Q3
6 quarters
|
|
|
BNY
3387
PUT
Bank of New York Mellon
BNY
$97.5B
| $1.48M | ﹤0.01% |
29,300
-93,100
| -76% | -$4.8M |
2017 Q3
6 quarters
|
|
3388
Genco Shipping & Trading
GNK
$1.19B
| $1.48M | ﹤0.01% |
197,973
+127,550
| +181% | +$1.04M |
2017 Q4
5 quarters
|
|
3389
FerroAtlántica
GSM
$811M
| $1.47M | ﹤0.01% |
718,617
+365,159
| +103% | +$831K |
2016 Q4
9 quarters
|
|
3390
Aclaris Therapeutics
ACRS
$545M
| $1.47M | ﹤0.01% |
245,804
+51,660
| +27% | +$342K |
2017 Q4
5 quarters
|
|
3391
NIO
NIO
$8.72B
| $1.47M | ﹤0.01% |
+288,448
| New | +$2.04M |
2019 Q1
0 quarters
|
|
|
WTRE
3392
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1.47M | ﹤0.01% |
+55,000
| New | +$1.48M |
2019 Q1
0 quarters
|
|
|
USX
3393
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.47M | ﹤0.01% |
222,477
+63,338
| +40% | +$492K |
2018 Q2
3 quarters
|
|
3394
Franklin Electric
FELE
$4.39B
| $1.47M | ﹤0.01% |
28,764
-33,527
| -54% | -$1.65M |
2013 Q2
23 quarters
|
|
3395
Onto Innovation
ONTO
$15.4B
| $1.47M | ﹤0.01% |
47,511
-7,773
| -14% | -$229K |
2013 Q2
23 quarters
|
|
3396
Tenable Holdings
TENB
$4.35B
| $1.46M | ﹤0.01% |
46,264
+43,047
| +1,338% | +$1.22M |
2018 Q3
2 quarters
|
|
|
UHT
3397
Universal Health Realty Income Trust
UHT
$520M
| $1.46M | ﹤0.01% |
19,343
-9,376
| -33% | -$668K |
2013 Q2
23 quarters
|
|
3398
CALL
Karyopharm Therapeutics
KPTI
$14.7M
| $1.46M | ﹤0.01% |
+16,667
| New | +$1.85M |
2019 Q1
0 quarters
|
|
3399
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.03B
| $1.46M | ﹤0.01% |
14,752
+6,423
| +77% | +$620K |
2018 Q3
2 quarters
|
|
3400
CALL
PagSeguro Digital
PAGS
$2.95B
| $1.46M | ﹤0.01% |
+48,800
| New | +$1.22M |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.